Pharmacology of Procedural Sedation
|
|
- Sophie Morrison
- 8 years ago
- Views:
Transcription
1 AACN Advanced Critical Care Volume 23, Number 4, pp , AACN ECG Challenges Earnest Alexander, PharmD, and Gregory M. Susla, PharmD Department Editors Pharmacology of Procedural Sedation Danyel Adams, PharmD Katelyn R. Dervay, PharmD, BCPS Many unpleasant, uncomfortable, and painful procedures take place throughout various areas in the hospital, including the emergency department, intensive care units, general medicine floors, and procedural areas. These procedures can include, but are not limited to, cardioversion, orthopedic injury reduction, burn debridement, endoscopy, bronchoscopy, and interventional imaging. 1,2 Patients may experience anxiety about undergoing these procedures as they can cause pain and discomfort. This anxiety can occur in both adults and children and can lead to agitation, an increased stress response, and ultimately a patient who is unable to cooperate. 2 The care provider s goal is to minimize pain and anxiety experienced by patients, to ensure a safer environment for both the patient and the health care team, and to increase the chance of a successful procedure. 1,2 Currently, procedural sedation is one of the best ways to accomplish this goal. Procedural sedation, previously known as conscious sedation, is defined as a technique of administering sedatives or dissociative agents with or without analgesics to induce a state that allows patients to tolerate unpleasant procedures while maintaining cardiorespiratory function. 2(p861) Multiple pharmacological agents are capable of providing procedural sedation and/or analgesia. Commonly used agents include propofol, benzodiazepines, ketamine, opioids, and etomidate. To facilitate the initiation of a procedure and timely recovery from sedation, clinicians want to choose agents that have a fast onset of action and a short duration of action, in addition to minimal adverse effects. The duration of action of these commonly used agents varies; therefore, the anticipated length of the procedure and the duration of sedation required should be considered for dosing and monitoring purposes. 1 Medications are commonly administered as bolus doses over continuous infusions to account for the length of the procedure. The potential adverse effects, most significantly hemodynamic changes and respiratory depression, of these sedative, analgesic, and dissociative agents should also be monitored. 3 Emergency equipment must be readily available, and all patients undergoing procedural sedation should be appropriately monitored. In this column, we discuss the commonly used agents and highlight pertinent differences in characteristics and appropriate monitoring practices for procedural sedation. Danyel Adams is Clinical Pharmacy Specialist, Emergency Medicine, Pharmacy Services, Baystate Medical Center, 759 Chestnut St, Springfield, MA (danyel.adams@baystatehealth.org). Katelyn R. Dervay is Pharmacotherapy Specialist, Emergency Medicine, Department of Pharmacy Services, Tampa General Hospital, Tampa, Florida. The authors declare no conflicts of interest. DOI: /NCI.0b013e31826e18d1 349
2 Drug Update AACN Receptors and Neurotransmitters Some available agents used for procedural sedation mimic the activity of γ-aminobutyric acid (GABA), which is known as an inhibitory neurotransmitter because of its activity at GABA receptors found on inhibitory neurons throughout the central nervous system. The 2 types of GABA receptors are GABA A and GABA B. General anesthetics and benzodiazepines act on GABA A, which is associated with a chloride ion channel, and activation of these receptors leads to hyperpolarization of the neuron, resulting in sedation, anxiolysis, and hypnosis. 4 In addition, some agents, such as ketamine, work by inhibiting N-methyl-D-aspartate (NMDA) receptors that are also found throughout the central nervous system. When NMDA receptors are activated by excitatory neurotransmitters, such as glutamate, an influx of calcium enters the neuron, resulting in neuronal excitation. Inhibition of these receptors prevents the excitation and results in a sedative and dissociative effect. 4 Opioid μ recepto rs, the pharmacological target for opioid analgesics, are G-protein coupled receptors and are found throughout the central and peripheral nervous system. 3 Stimulation leads to a cascade of events that ultimately inhibit excitability of the neurons and neurotransmitter release and result in analgesia, euphoria, and sedation. 4 Propofol Propofol facilitates sedation and amnesia through its activity on the GABA and NMDA receptors but does not elicit analgesic properties. 5 Because of the lack of analgesic activity, an additional agent for pain control is needed for painful procedures. 3 Propofol s fast onset of action and short duration of action make it an ideal sedative agent for short procedures (Table 1). 5 Reduced recovery times were seen with propofol when compared with midazolam in a study conducted in an emergency department. 2 The reduced recovery time can potentially facilitate faster discharge times and increase patient satisfaction. Adverse effects of propofol include respiratory depression and hypotension. These cardiopulmonary effects can be enhanced by coadministration of other sedative or analgesic agents. 3 In the setting of procedural sedation, propofol is administered as an initial intravenous bolus dose and can be followed by additional bolus doses if needed, depending on the patient and the duration of the procedure (Table 2). To prevent dosedependent hypotension, which is more profound after bolus administration but can occur at any Table 1: Pharmacokinetics and Cardiopulmonary Effects of Sedative and Analgesic Agents a Medication Name Onset of Action (IV) Duration of Action Cardiopulmonary Effects Propofol s 5-10 min Decreased blood pressure Respiratory depression Opioids Fentanyl 1-2 min min Decreased blood pressure Morphine 5-10 min 3-5 h Respiratory depression Hydromorphone 5-10 min 4-5 h Benzodiazepines Midazolam 2-5 min min Decreased blood pressure Lorazepam min 4-6 h Respiratory depression Diazepam 2-5 min min Etomidate s 3-5 min None Ketamine s 60 min Decreased blood pressure Increased heart rate Ketofol s 60 min None (theoretically) Abbreviation: IV, intravenous. a Data from references 5, 6, 8 to 10, 12, and 14 to
3 VOLUME 23 NUMBER 4 OCTOBER DECEMBER 2012 Drug Update Table 2: Initial Dosing and Titration of Sedative and Analgesic Agents and Adjunct Medications a Medication Name Initial Bolus Dosing (IV) Titration Opioids Fentanyl mcg/kg mcg/kg every 1-3 min as needed Morphine 0.1 mg/kg or 1-2 mg mg/kg or 1-2 mg every 5-15 min as needed (max 15 mg) Hydromorphone mg mg every 5-10 min Sedatives Midazolam 0.1 mg/kg 0.1 mg/kg every 2 min as needed Lorazepam 1-2 mg 1 mg every 5-10 min as needed Diazepam Up to 10 mg (varies based on Not recommended procedure) Anesthetics Propofol 1 mg/kg 0.5 mg/kg every 3-5 min as needed Etomidate mg/kg 0.05 mg/kg every 3-5 min as needed Ketamine 1-2 mg/kg 0.5 mg/kg every 5-10 min as needed Ketofol 0.5 mg/kg propofol and 0.5 mg/kg ketamine (1:1 ratio) Not recommended Antisialogogues Atropine 0.01 mg/kg (max 0.4 mg) Prior to or with administration of ketamine Glycopyrrolate mg/kg (max 0.2 mg) Prior to or with administration of ketamine Antidote medications Naloxone Reversal: 1-2 mcg/kg 1-2 mcg/kg every 2-3 min (max 10 mg) Flumazenil Reversal: mcg/kg or 0.2 mg over 15 s mcg/kg or 0.2 mg every 60 s (max 1 mg) Abbreviations: IV, intravenous; max, maximum. a Data from references 3, 5, 6, 8 to 10, and 12 to 22. time, give the initial bolus in small increments. This prolonged delivery time has the potential to result in less-significant hemodynamic changes. Propofol use has the potential to lead to propofol-related infusion syndrome. 5 However, this syndrome is more common with larger doses and extended infusions, so it is not a major concern with the smaller bolus doses used for procedural sedation. Note that propofol is manufactured in a lipid emulsion and should not be used in patients with egg and soy allergies. Benzodiazepines Benzodiazepines, such as lorazepam, midazolam, and diazepam, are well known as anxiolytic agents. These agents can also cause sedation and retrograde amnesia. 6 These pharmacological effects are a result of activity at the GABA receptors. The class as a whole lacks analgesic properties, similar to propofol; therefore, coadministration of an analgesic agent is necessary prior to the initiation of painful procedures. Of the benzodiazepines, midazolam is most commonly used in the setting of procedural sedation because of its fast onset and short duration of action (Table 1). The adverse effects associated with benzodiazepine use are similar to those of other sedative agents and include respiratory depression and hypotension, which can be more profound when a combination of sedative and analgesic agents is given. 6 When benzodiazepines are administered with other agents, such as opioids, decreased initial bolus doses should be considered because of the possibility of additive cardiopulmonary adverse effects (Table 1). Because of these additive effects, decreased doses should also be considered if additional doses are needed to complete the procedure. 351
4 Drug Update AACN In addition to hemodynamic and respiratory effects, the administration of benzodiazepines can result in paradoxical excitement in 10% to 15% of patients. This reaction can manifest as agitation, hyperactivity, increased anxiety, or sometimes aggression and is most commonly seen in children and older adults. 3,7 Clinicians may choose to warn family members and patients about this possible reaction, as it is unexpected after the administration of a sedative agent. If this type of reaction does occur, the patient should be kept safe and monitored closely. Flumazenil, to be discussed later, may be considered for severe cases. 7 Etomidate Etomidate was introduced in 1972 and exerts its pharmacological effect, primarily sedation, through its activity at the GABA receptors. Sedation is facilitated via bolus dosing (Table 2). Because etomidate lacks analgesic properties, analgesic agents should be coadministered to promote patient comfort and cooperation during painful procedures. 8 The rapid onset of sedation and rapid recovery time (Table 1) associated with etomidate are desirable for shorter procedures, such as cardioversions or reductions, and may lead to more rapid discharge and potentially increased patient satisfaction. Etomidate differs from other sedative agents with regard to its minimal effect on hemodynamics 3 ; for this reason, it is an appropriate choice for patients with baseline hypotension and hemodynamic instability. Clinicians should note that a myoclonus reaction, a period of involuntary twitching of the muscles, may be seen after administration, as this reaction could be perceived as increased agitation or a seizure. 8 Adrenal suppression may be experienced following etomidate administration; however, this effect is transient and can be treated with exogenous steroids if needed. The suspected mechanism for this effect is inhibition of endogenous steroid production, which can last for 12 to 14 hours after a single dose. Etomidate is not used in repeated doses or as a continuous infusion in the intensive care setting for this reason. 3 Opioids Opioids, such as fentanyl, morphine, and hydromorphone, are agents commonly used throughout the hospital setting for reduction and control of pain. The analgesic effect is exerted as a result of activity at the μ receptors. 9 Fentanyl is the opioid most commonly used for procedural sedation and is often used in addition to another sedative or dissociative agent. Onset of analgesia with fentanyl is rapid following administration, and because of its short halflife, the recovery time is short (Table 1). 9 Dosedependent respiratory depression is associated with the use of opioids, which can result in an additive effect when other sedative agents, such as midazolam or propofol, are coadministered. All opioids have the potential to cause hypotension, especially when used in combination with other sedative agents. This effect will be more profound in patients with baseline hypovolemia. 3 Fentanyl has a lesser effect on hemodynamics when compared with other opioids, such as morphine (known to cause hypotension due to venodilation and histamine release). 9 Because fentanyl has fewer hemodynamic effects, a fast onset, and a short duration of action, it stands out among this class of agents as the ideal opioid for procedural sedation. Although hydromorphone is widely used in the intensive care setting for analgesic purposes, it is not commonly used for procedural sedation. Ketamine Ketamine historically has been used the most in the pediatric population; however, more literature is becoming available on its use, efficacy, and safety in the adult patient population. It is a unique procedural sedation agent, because it has multiple pharmacological properties that are desirable. It is considered a dissociative agent that creates a trance-like state and causes amnesia in patients. In addition to its sedative and dissociative effects, ketamine has analgesic activity. 1 This dual sedative-analgesic activity is beneficial, because only a single agent may be needed for painful procedures. In addition, ketamine may be a potential option for patients with drug abuse habits who have developed tolerance to opioids, benzodiazepines, or propofol. 1 It exerts its activity via the NMDA receptors and inhibits the binding of glutamate. 10 Ketamine has a rapid onset of action when given as a bolus dose (Table 2) but has a longer half-life than other sedative agents, which leads to longer recovery times (up to 60 minutes) (Table 1). 10 The longer recovery times, compared with those for agents such as propofol, may make ketamine a lessappealing option for some short procedures, because increased nursing resources may be required as a result of a longer period of monitoring following the procedure. Conversely, the 352
5 VOLUME 23 NUMBER 4 OCTOBER DECEMBER 2012 Drug Update longer duration of action can prove useful in lengthy procedures. Ketamine also differs from other agents with respect to adverse effects. Unlike the reduction in blood pressure seen with other sedative agents, a dose-related increase in heart rate and blood pressure is seen after administration of ketamine, potentially making it a good option for patients who are hypotensive or who may be at increased risk of developing hypotension with other sedative agents. 3 In addition, an increase in inotropic effects is noted. The increased inotropy causes increased myocardial oxygen demand; therefore, ketamine should be used with caution in patients with ischemic heart disease. 3 Respiratory function is not significantly affected. An emergence reaction can occur with ketamine, both when the medication is active and when its dissociative and sedative effects are waning. 10 This reaction is due to the inhibition of glutamate and can manifest as dreaming, nightmares, or hallucinations due to confusion between imaginary and real stimuli. 1 Benzodiazepines can prevent and manage these emergence reactions and should be given toward the end of the procedure. Older children and adults should be encouraged to think pleasant thoughts prior to administration in order to decrease these unpleasant emergence reactions. In addition, reducing auditory, visual, and physical stimuli may reduce associated agitation. 3 Increased intracranial pressure has also been associated with ketamine, although controversy is noted in the literature regarding this effect. 3 Previous literature suggests that increased intracranial pressure can occur after administration of a single dose of ketamine. Finally, increased oral secretions, which can be managed with atropine or glycopyrrolate, and nystagmus have been noted with the administration of ketamine (Table 2). 1,11 Clinicians should consider warning family members, especially of children, of the eye movements and the aimless stare they may observe. Ketofol The literature on procedural sedation shows an increase in the use of ketofol. It is not a Food and Drug Administration-approved agent in its own right but is a combination of ketamine and propofol. This combination can represent either coadministration via separate bolus doses or the mixing of the 2 agents together in a single syringe to be used for intravenous administration. The concept behind this combination of agents is to balance the hemodynamic adverse effects by administering smaller doses of each. The combination is usually dosed in a 1:1 ratio. 12 In theory, the increase in heart rate and blood pressure with ketamine should counteract the hypotension associated with propofol administration and vice versa. 1 Decreased hypersalivation and fewer and less severe emergence reactions have been noted, because the dose of ketamine is less than that which causes the previously mentioned unwanted effects. 12 In addition, ketamine has analgesic properties, so the addition of an analgesic agent would not be necessary. However, clinicians should note the following considerations before using ketofol. First, the pharmacokinetic differences between the agents need to be examined. Propofol is shorter acting than ketamine, so if additional sedation is needed to complete a procedure, redosing of ketofol could lead to accumulation and extended action of ketamine. A recommendation would be to consider rebolusing with propofol alone and not with the combination of agents if additional sedation is needed. 11 Second, stability data on the combination in a single syringe are still limited. Also, if a patient has a reaction to the combination, the causative agent, propofol or ketamine, could not be determined. Finally, evidence for use is still limited. Studies have been small but are increasing, and additional studies are needed to validate the efficacy of ketofol for procedural sedation. 1 Monitoring and Managing Cardiopulmonary Events As previously stated, monitoring is essential for patients undergoing procedural sedation. Because of the hemodynamic and respiratory adverse effects that can accompany the use of these sedative, analgesic, and dissociative agents, patients vital signs should be closely monitored in addition to patients comfort. Pulse oximetry and cardiac monitoring should be used to assess heart rate, blood pressure, respiratory rate, and oxygen saturation. 2 Physical monitoring of patients should also be incorporated to identify additional signs of hemodynamic instability, respiratory distress, and comfort, including such effects as cyanosis, chest wall motion, and increased agitation. Depth of sedation also should be assessed by monitoring patients responsiveness. 3 Because of the extensive monitoring required during procedural sedation, the practitioner sedating and monitoring the patient should not be responsible for the 353
6 Drug Update AACN procedure itself; assistance should be sought. 13 Note that the monitoring period does not end with the completion of the procedure; it should be continued throughout the recovery phase until sedation has fully waned. Emergency equipment should be readily available throughout the procedure and the recovery phase in case a negative cardiopulmonary event occurs. In the event of cardiopulmonary events, the offending agent(s) should be discontinued. Supplemental oxygen, suction, continuous positive airway pressure, or mechanical ventilation (if needed) can be used to manage respiratory depression. 13 Fluids can be given to help alleviate hypotension. In cases of opioid or benzodiazepine use, sedation and adverse effects can be mitigated with the administration of antidotes. Naloxone will facilitate the reversal of opioid effects, and administration should be completed as a titration of the dose in small increments. This method of administration allows for the reversal of adverse effects without complete reversal of analgesia. 3 Longterm opioid users have the potential to experience withdrawal symptoms if the opioid effect is completely negated. Reversal of benzodiazepine effects can be facilitated by the administration of flumazenil. The administration of flumazenil is recommended for use in acute benzodiazepine overdose only in patients not regularly taking benzodiazepines. 3 The use of flumazenil in chronic users of benzodiazepine can lead to withdrawal symptoms and potentially seizures; therefore, its use is contraindicated in this patient population. Long-term substance use and abuse should be considered before the administration of opioid and benzodiazepine reversal agents. No reversal agents are available for other sedative and dissociative agents, such as etomidate, propofol, and ketamine, and patients experiencing cardiopulmonary adverse effects should be monitored and managed with supportive care. Summary Propofol, opioids, benzodiazepines, and ketamine are sedative and analgesic agents commonly used during painful procedures requiring sedation and analgesia. Ketofol may be considered; however, more efficacy data are needed to fully support its use. In the era of drug shortages, clinicians should be aware of, and familiar with, all the sedative and analgesic agents for procedural sedation, in case a preferred agent is unavailable. Multiple adverse effects are associated with the use of these sedative and analgesic agents, so monitoring is essential, and emergency equipment should be readily available. Familiarity with the pharmacokinetic differences and adverse effects of the various agents can help clinicians choose appropriate medications for specific procedures and patients. REFERENCES 1. Sih K, Campbell SG, Tallon JM, Magee K, Zed PJ. Ketamine in adult emergency medicine: controversies and recent advances. Ann Pharmacother. 2011;45: Rahman NHNA, Hashim A. The use of propofol for procedural sedation and analgesia in the emergency department: a comparison with midazolam. Emerg Med J. 2001;28: Tobias JD, Leder M. Procedural sedation: a review of sedative agents, monitoring, and management of complications. Saudi J Anesth. 2011;5(4): Grilly DM. Drugs Human Behav. 5th ed. New York, NY: Pearson Education Inc; Package Information: Diprivan, propofol. Schaumburg, IL: APP Pharmaceuticals; Package Information: Versed, midazolam. Nutley, NJ: Roche Laboratories Inc; Paton C. Benzodiazepines and disinhibition: a review. Psychiatrist. 2002;26: Package Information: Amidate, etomidate. Lake Forest, IL: Hospira Inc; Package Information: Fentanyl citrate. Lake Forest, IL: Hospira Inc; Package Information: Ketamine hydrochloride. Lake Forest, IL: Bioniche Pharma USA LLC; Green SM, Andolfatto G, Krauss B. Ketofol for procedural sedation? Pro and con. Ann Emerg Med. 2011;57(5): David M, Shipp J. A randomized controlled trial of ketamine/propofol versus propofol alone for emergency department procedural sedation in children. Ann Emerg Med. 2011;57(5): American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology. 1996;84: Morphine sulfate. In: DRUGDEX System [Internet database]. 15. Hydromorphone hydrochloride. In: DRUGDEX System [Internet database]. Greenwood Village, CO: Thomson Reuters (Healthcare) Inc. Updated periodically. Accessed May 13, Lorazepam. In: DRUGDEX System [Internet database]. 17. Diazepam. In: DRUGDEX System [Internet database]. 18. Flumazenil. In: DrugPoints System [Internet database]. 19. Naloxone hydrochloride. In: DrugPoints System [Internet database]. Greenwood Village, CO: Thomson Reuters (Healthcare) Inc. Updated periodically. Accessed May 13, Baker SN, Weant KA. Procedural sedation and analgesia in the emergency department. J Pharm Prac. 2011;24(2): Shabanie A. Conscious sedation for interventional procedures: a practical guide. Tech Vasc Interv Radiol. 2006;9(2): Policy and Procedure on Conscious Sedation/Analgesia for Adults. Published Accessed June 29,
EMS Branch / Office of the Medical Director. Active Seziures (d) Yes Yes Yes Yes. Yes Yes No No. Agitation (f) No Yes Yes No.
M07 Medications 2015-07-15 All ages EMS Branch / Office of the Medical Director Benzodiazepines Primary Intermediate Advanced Critical INDICATIONS Diazepam (c) Lorazepam (c) Midazolam (c) Intranasal Midazolam
More information*Reflex withdrawal from a painful stimulus is NOT considered a purposeful response.
Analgesia and Moderate Sedation This Nebraska Board of Nursing advisory opinion is issued in accordance with Nebraska Revised Statute (NRS) 71-1,132.11(2). As such, this advisory opinion is for informational
More informationDRAFT 7/17/07. Procedural Sedation and Rapid Sequence Intubation (RSI) Consensus Statement
Procedural Sedation and Rapid Sequence Intubation (RSI) Consensus Statement Many patients with emergency medical conditions in emergency and critical care settings frequently experience treatable pain,
More informationPatient Care Services Policy & Procedure Title: No. 8720-0059
Page: 1 of 8 I. SCOPE: This policy applies to Saint Francis Hospital, its employees, medical staff, contractors, patients and visitors regardless of service location or category of patient. This policy
More informationDrug Shortage Alert 8/1/2014
Headquarters 500 Midway Drive Mount Prospect, Illinois 60056-5811 USA Main Telephone +1 847 827-6869 Customer Service +1 847 827-6888 Facsimile +1 847 827-6886 Email info@sccm.org www.sccm.org Drug Shortage
More informationMedical Coverage Policy Monitored Anesthesia Care (MAC)
Medical Coverage Policy Monitored Anesthesia Care (MAC) Device/Equipment Drug Medical Surgery Test Other Effective Date: 9/1/2004 Policy Last Updated: 1/8/2013 Prospective review is recommended/required.
More informationCH CONSCIOUS SEDATION
Summary: CH CONSCIOUS SEDATION It is the policy of Carondelet Health that moderate conscious sedation of patients will be undertaken with appropriate evaluation and monitoring. Effective Date: 9/4/04 Revision
More informationAlcohol Withdrawal. Introduction. Blood Alcohol Concentration. DSM-IV Criteria/Alcohol Abuse. Pharmacologic Effects of Alcohol
Pharmacologic Effects of Alcohol Alcohol Withdrawal Kristi Theobald, Pharm.D., BCPS Therapeutics III Fall 2003 Inhibits glutamate receptor function (NMDA receptor) Inhibits excitatory neurotransmission
More informationPROCEDURAL SEDATION/ANALGESIA NCBON Position Statement for RN Practice
PROCEDURAL SEDATION/ANALGESIA NCBON Position Statement for RN Practice P.O. BOX 2129 Raleigh, NC 27602 (919) 782-3211 FAX (919) 781-9461 Nurse Aide II Registry (919) 782-7499 www.ncbon.com Issue: Administration
More informationWho Should Participate*
earn 25 contact hours! For as little as $49. 95 Announcing: Sedation Clinical Competency Program Finally A practical solution to satisfy formal training, credentialing, and competency-based educational
More informationPhilip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth
Philip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth I. II. Background A. AWS can occur in anyone who consumes alcohol B. Risk correlates
More informationPHSW Procedural Sedation Post-Test Answer Key. For the following questions, circle the letter of the correct answer(s) or the word true or false.
PHSW Procedural Sedation Post-Test Answer Key 1 1. Define Procedural (Conscious) Sedation: A medically controlled state of depressed consciousness where the patient retains the ability to continuously
More informationSick, Sicker, Sickest: Anesthesia in the Critically Ill Patient
Sick, Sicker, Sickest: Anesthesia in the Critically Ill Patient Kim Spelts, CVT, VTS (Anesthesia), CCRP, CCMT Peak Performance Veterinary Group No anesthetic procedure is entirely safe, but critically
More informationWITHDRAWAL OF ANALGESIA AND SEDATION
WITHDRAWAL OF ANALGESIA AND SEDATION Patients receiving analgesia and/or sedation for longer than 5-7 days may suffer withdrawal if these drugs are suddenly stopped. To prevent this happening drug doses
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: CSD - Suboxone Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Analgesics and Antipyretics (Opiate Partial Agonists) Client: County of San
More informationConscious Sedation Policy
PURPOSE Provide guidelines to ensure safe and consistent process for patient selection, administration, monitoring and discharge care of patients receiving conscious sedation. Conscious sedation refers
More informationTargeting patients for use of dexmedetomidine
Targeting patients for use of dexmedetomidine H a n n a h W u n s c h, M D M S c H e r b e r t I r v i n g A s s i s t a n t P r o f e s s o r o f A n e s t h e s i o l o g y & E p i d e m i o l o g y
More informationMississippi Board of Nursing
Mississippi Board of Nursing Regulating Nursing Practice www.msbn.state.ms.us 713 Pear Orchard Road, Suite 300 Ridgeland, MS 39157 Administration and Management of Intravenous (IV) Moderate Sedation POSITION
More informationObjectives. Important Principles
Management of the Intubated Patient Christopher J. Edwards, PharmD, BCPS Clinical Pharmacist - Emergency Medicine March 19 th, 2013 REPS EC SAG 2 Objectives Describe the rationale for post intubation analgesia
More informationANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY. Guidelines for Use of Intravenous Isoproterenol
ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY Guidelines for Use of Intravenous Isoproterenol Major Indications Status Asthmaticus As a last resort for
More informationSaint Thomas Hospital Protocol. Protocol Title: Terminal Weaning from Ventilator Protocol No.: V-09. Medical Staff departments
Saint Thomas Hospital Protocol Protocol No.: V-09 Operating Unit(s) Medical Staff departments Important s: Affected: affected:! Hospital! Medicine of Origin: 2/00 " Regional Network! Surgery Reviewed:
More information7. We often use Marcaine in tonsillectomies for longer acting analgesia. What is the dose? What are the particular side effects?
7. We often use Marcaine in tonsillectomies for longer acting analgesia. What is the dose? What are the particular side effects? Marcaine dosing per uptodate is Local anesthesia: Infiltration: 0.25% infiltrated
More informationKetamine in Tactical Combat Casualty Care. DHB Decision Briefing. John Gandy, MD Trauma and Injury Subcommittee
Ketamine in Tactical Combat Casualty Care DHB Decision Briefing John Gandy, MD Trauma and Injury Subcommittee Agenda Importance of Early Pain Control History of Battlefield Analgesia Current State of Battlefield
More information4/18/14. Background. Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients. Background. Signs and Symptoms of Withdrawal
Background 1 Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients Alyssa Cavanaugh, PharmD PGY1 Pharmacy Resident Children s Hospital of Michigan **The speaker has no actual or
More informationMOH CLINICAL PRACTICE GUIDELINES 2/2008 Prescribing of Benzodiazepines
MOH CLINICL PRCTICE GUIELINES 2/2008 Prescribing of Benzodiazepines College of Family Physicians, Singapore cademy of Medicine, Singapore Executive summary of recommendations etails of recommendations
More informationMODERATE SEDATION RECORD (formerly termed Conscious Sedation)
(POLICY #DOC-051) Page 1 of 6 WELLSPAN HEALTH - YORK HOSPITAL NURSING POLICY AND PROCEDURE Dates: Original Issue: September 1998 Annual Review: March 2012 Revised: March 2010 Submitted by: Brenda Artz
More informationAcute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC
Acute Pain Management in the Opioid Dependent Patient Maripat Welz-Bosna MSN, CRNP-BC Relieving Pain in America (IOM) More then 116 Million Americans have pain the persists for weeks to years $560-635
More informationGuidelines for the Use of Naloxone in Palliative Care in Adult Patients
Guidelines for the Use of Naloxone in Palliative Care in Adult Patients Date Approved by Network Governance May 2012 Date for Review May 2015 Changes between Version 1 and 2 1. Guideline background 2.
More informationPOST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics
POST-TEST University of Wisconsin Hospital & Clinics True/False/Don't Know - Circle the correct answer T F D 1. Changes in vital signs are reliable indicators of pain severity. T F D 2. Because of an underdeveloped
More informationThe American Society of Anesthesiologists (ASA) has defined MAC as:
Medical Coverage Policy Monitored Anesthesia Care (MAC) sad EFFECTIVE DATE: 09 01 2004 POLICY LAST UPDATED: 11 04 2014 OVERVIEW The intent of this policy is to address anesthesia services for diagnostic
More informationClinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients
Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients Developed by the Mid Atlantic Renal Coalition and the Kidney End of Life Coalition September 2009 This project was supported,
More information1.4.4 Oxyhemoglobin desaturation
Critical Care Therapy and Respiratory Care Section Category: Clinical Section: Clinical Monitoring Title: Monitoring of Patients Undergoing Conscious Sedation Policy #: 09 Revised: 05/00 1.0 DESCRIPTION
More informationNurses Self Paced Learning Module on Pain Management
Nurses Self Paced Learning Module on Pain Management Dominican Santa Cruz Hospital Santa Cruz, California Developed by: Strategic Planning Committee Dominican Santa Cruz Hospital 1555 Soquel Drive Santa
More informationPain Management in the Critically ill Patient
Pain Management in the Critically ill Patient Jim Ducharme MD CM, FRCP President-Elect, IFEM Clinical Professor of Medicine, McMaster University Adjunct Professor of Family Medicine, Queens University
More informationWithdrawal symptoms in long term sedation exposure of pediatric intensive care patients
CLINICAL PRACTICE Withdrawal symptoms in long term sedation exposure of pediatric intensive care patients Susanne Kotz University Medical Center Hamburg-Eppendorf, Germany Correspondence: Susanne Kotz.
More informationReview of Pharmacological Pain Management
Review of Pharmacological Pain Management CHAMP Activities are possible with generous support from The Atlantic Philanthropies and The John A. Hartford Foundation The WHO Pain Ladder The World Health Organization
More informationEvaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients
Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients Jennifer Kuhns, Pharm.D. Pharmacy Practice Resident Children s Hospital of Michigan **The speaker has no actual or potential
More informationACLS Cardiac Arrest Algorithm Neumar, R. W. et al. Circulation 2010;122:S729-S767
ACLS Cardiac Arrest Algorithm Neumar, R. W. et al. Circulation 2010;122:S729-S767 Copyright 2010 American Heart Association ACLS Cardiac Arrest Circular Algorithm Neumar, R. W. et al. Circulation 2010;122:S729-S767
More informationPain Medication Taper Regimen Time frame to taper off 30-60 days
Pain Medication Taper Regimen Time frame to taper off 30-60 days Medication to taper Taper Regimen Comments Methadone Taper by no more than 25% Morphine Taper by no more than 25% Tramadol Taper by no more
More informationUniversity of Kentucky / UK HealthCare Policy and Procedure
University of Kentucky / UK HealthCare Policy and Procedure Policy # A08-115 Title/Description: Sedation for Procedures Purpose: To provide guidelines for providers administering and monitoring sedation
More informationDEFINITIONS Minimal Sedation: Moderate Sedation/Analgesia: Deep Sedation/Analgesia: Anesthesia:
Policy: Conscious Sedation Owner: CNO, Anesthesia Department, Medical Staff Initiated: 08/2010 Version: 2 Last Approval Date: 8/2012 Reference: S. Smith, D. Duell, B. Martin, Clinical Nursing Skills, Basic
More informationCHAPTER 8 MODERATE SEDATION/ANALGESIA
MODERATE SEDATION/ANALGESIA Linda Wilson, PhD, RN, CPAN, CAPA, BC, CNE Christine Price, MSN, RN, CPAN, CAPA H. Lynn Kane, MSN, MBA, RN, CCRN Linda J. Webb, MSN, RN, CPAN OVERVIEW Purpose: The orientee
More information9/16/2010. Contact Information. Objectives. Analgesic Ketamine (Ketalar )
Analgesic Ketamine (Ketalar )..the long and winding road to clinical practice Contact Information Lois Pizzi BSN, RN-BC Inpatient Pain Management Clinician UPMC Presbyterian Shadyside pizzilj@upmc.edu
More informationHOWS AND WHYS OF CRI ANALGESIA IN SMALL ANIMALS Luisito S. Pablo, DVM, MS, Diplomate ACVA University of Florida, Gainesville, Florida
HOWS AND WHYS OF CRI ANALGESIA IN SMALL ANIMALS Luisito S. Pablo, DVM, MS, Diplomate ACVA University of Florida, Gainesville, Florida Management of severe pain in small animals continues to be a challenge
More informationTitle/Subject Procedural Sedation and Analgesia Page 1 of 10
Policy Procedural Sedation and Analgesia Page 1 of 10 Scope: Providers and nurses (M.D., D.O., D.M.D., D.D.S., A.P.R.N., P.A., R.N.) with appropriate privileges and who have successfully demonstrated adequate
More informationAlcohol Withdrawal Syndrome & CIWA Assessment
Alcohol Withdrawal Syndrome & CIWA Assessment Alcohol Withdrawal Syndrome is a set of symptoms that can occur when an individual reduces or stops alcoholic consumption after long periods of use. Prolonged
More informationPackage leaflet: Information for the patient. Naloxone Hydrochloride 20 micrograms / ml Solution for Injection Naloxone hydrochloride
A leaflet will be included in each pack. The leaflet will consist of a Technical Information Leaflet and a Patient Information Leaflet. The two leaflets will be easily separatable. The text of the Technical
More informationSubstitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015
Substitution Therapy for Opioid Dependence The Role of Suboxone Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015 Objectives Recognize the options available in treating opioid
More informationNaloxone treatment of opioid overdose
Naloxone treatment of opioid overdose Opioids Chemicals that act in the brain to relieve pain, often use to suppress cough, treat addiction, and provide comfort After prolonged use of opioids, increasing
More informationRecommendations for Alternative Analgesic and Sedative Agents in the Setting of Drug Shortages
Recommendations for Alternative Analgesic and Sedative Agents in the Setting of Drug Shortages Gail Gesin, PharmD* Clinical Phramacist for Trauma Critical Care Carolinas Medical Center Charlotte, North
More informationConscious Sedation: A Primer for Outpatient Procedures
Clinical Review Article Conscious Sedation: A Primer for Outpatient Procedures Stuart Spitalnic, MD Christopher Blazes, MD Angela C. Anderson, MD Many painful or anxiety-provoking procedures can be successfully
More informationCorporate Medical Policy
File Name: anesthesia_services Origination: 8/2007 Last CAP Review: 1/2016 Next CAP Review: 1/2017 Last Review: 1/2016 Corporate Medical Policy Description of Procedure or Service There are three main
More informationAtrial Fibrillation in the ICU: Attempting to defend 4 controversial statements
Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements Salmaan Kanji, Pharm.D. The Ottawa Hospital The Ottawa Hospital Research Institute Conflict of Interest No financial, proprietary
More informationSymptom Based Alcohol Withdrawal Treatment
Symptom Based Alcohol Withdrawal Treatment -Small Rural Hospital- Presenter CDR Dwight Humpherys, DO dwight.humpherys@ihs.gov Idaho State University Baccalaureate Nursing Program Lake Erie College of Osteopathic
More informationSedation and pain management in interventional radiology
Key words: Conscious sedation; analgesia; interventional radiology; anaesthesia interventional radiology Marc Kalinowski and Hans-Joachim Wagner Department of Diagnostic Radiology, Philipps-University
More informationtable of contents drug reference
table of contents drug reference ADULT DRUG REFERENCE...155 161 PEDIATRIC DRUG REFERENCE...162 164 PEDIATRIC WEIGHT-BASED DOSING CHARTS...165 180 Adenosine...165 Amiodarone...166 Atropine...167 Defibrillation...168
More informationCrash Cart Drugs Drugs used in CPR. Dr. Layla Borham Professor of Clinical Pharmacology Umm Al Qura University
Crash Cart Drugs Drugs used in CPR Dr. Layla Borham Professor of Clinical Pharmacology Umm Al Qura University Introduction A list of the drugs kept in the crash carts. This list has been approved by the
More informationPotential Effects Of Significant Alcohol Withdrawal And Surgeries
Alcohol Use Dates Back 7,000 to 10,000 Years Though Scientists Still Debate the Mechanisms of Hangovers Proposed Causes of Hangovers Acute ethanol withdrawal Ethanol can alleviate symptoms Acetaldehyde
More informationFairfield Medical Center Attn: Medical Staff Services 401 N. Ewing Street Lancaster, Ohio 43130 Fax~ 740-687-8143
SUBJECT: Conscious Sedation Module* Please find enclosed the required Conscious Sedation Module from Fairfield Medical Center. Please be sure to fill out the answer sheet completely. The Post-Assessment
More informationUniversity of Michigan Alcohol Withdrawal Guidelines Overview
University of Michigan Alcohol Withdrawal Guidelines Overview The following document contains the University of Michigan Alcohol Withdrawal Guidelines. These guidelines were developed through an intensive
More informationEmergency Room Treatment of Psychosis
OVERVIEW The term Lewy body dementias (LBD) represents two clinical entities dementia with Lewy bodies (DLB) and Parkinson s disease dementia (PDD). While the temporal sequence of symptoms is different
More information!!! BOLUS DOSE IV. Use 5-10 mcg IV boluses STD ADRENALINE INFUSION. Use IM adrenaline in advance of IV dosing!
ADRENALINE IVI BOLUS IV Open a vial of 1:1000 ADRENALINE 1 mg /ml Add 1 ml to 9 ml N/Saline = 1mg adrenaline in 10 ml (or 100 mcg/ml) Add 1 ml 1:10,000 to 9 ml N/Saline = 100 mcg adrenaline in 10 ml (or
More informationACLS PHARMACOLOGY 2011 Guidelines
ACLS PHARMACOLOGY 2011 Guidelines ADENOSINE Narrow complex tachycardias or wide complex tachycardias that may be supraventricular in nature. It is effective in treating 90% of the reentry arrhythmias.
More informationVA SAN DIEGO HEALTHCARE SYSTEM MEMORANDUM 118-28 SAN DIEGO, CA
GUIDELINES FOR PATIENT-CONTROLLED ANALGESIA (PCA) AND PATIENT- CONTROLLED EPIDURAL ANALGESIA (PCEA) FOR ACUTE PAIN MANAGEMENT 1. PURPOSE: To assure the safe and effective use of patient controlled analgesia
More informationCommon Surgical Procedures in the Elderly
Common Surgical Procedures in the Elderly From hip and knee replacements to cataract and heart surgery, America s elderly undergo 20% of all surgical procedures. For a group that comprises only 13% of
More informationPrevention and Treatment of Opioid and Benzodiazepine Withdrawal
1.0 Introduction The purpose of this guideline is to ensure that patients who are at risk of developing withdrawal symptoms can be weaned off opioids and benzodiazepines in a timely fashion. It is appropriate
More informationGeneral PROVIDER INITIALS: PHYSICIAN ORDERS
Height Weight Allergies If appropriate for patient condition, please consider the following order sets: Initiate Electrolyte Replcement: Med/Surg, Med/Surg Tele Physician Order #842 General Vital Signs
More informationCenter for Medicaid and State Operations/Survey and Certification Group
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard, Mail Stop S2-12-25 Baltimore, Maryland 21244-1850 Center for Medicaid and State Operations/Survey
More informationMANAGEMENT OF CHRONIC NON MALIGNANT PAIN
MANAGEMENT OF CHRONIC NON MALIGNANT PAIN Introduction The Manitoba Prescribing Practices Program (MPPP) recognizes the important role served by physicians in relieving pain and suffering and acknowledges
More informationAcute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction
Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction June 9, 2011 Tufts Health Care Institute Program on Opioid Risk Management Daniel
More informationA Patient s Guide to PAIN MANAGEMENT. After Surgery
A Patient s Guide to PAIN MANAGEMENT After Surgery C o m p a s s i o n a n d C o m m i t m e n t A Patient s Guide to Pain Management After Surgery If you re facing an upcoming surgery, it s natural to
More informationProcedural Sedation Consensus Statement
Procedural Sedation Consensus Statement The immediate availability of interventions including procedural sedation is critical to serving the needs of our patients. Preserving life, restoring health, and
More informationPREPARATIONS: Adrenaline 1mg in 1ml (1:1000) Adrenaline 100micrograms in 1ml (1:10,000)
ADRENALINE Acute hypotension Via a CENTRAL venous line Initially 100-300 nanograms/kg/minute 0.1-0.3 microgram/kg/minute adjusted according to response up to a maximum of 1.5 micrograms/kg/minute. Increase
More informationUpdate and Review of Medication Assisted Treatments
Update and Review of Medication Assisted Treatments for Opiate and Alcohol Use Disorders Richard N. Whitney, MD Medical Director Addiction Services Shepherd Hill Newark, Ohio Medication Assisted Treatment
More informationVISTARIL (hydroxyzine pamoate) Capsules and Oral Suspension
VISTARIL (hydroxyzine pamoate) Capsules and Oral Suspension DESCRIPTION Hydroxyzine pamoate is designated chemically as 1-(p-chlorobenzhydryl) 4- [2-(2-hydroxyethoxy) ethyl] diethylenediamine salt of 1,1
More informationNaltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance
Naltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance Introduction Indication/Licensing information: Naltrexone is licensed for use as an additional therapy, within
More informationEquine Sedation, Anesthesia and Analgesia
Equine Sedation, Anesthesia and Analgesia Janyce Seahorn, DACVAA, DACVIM-LA, DACVECC Lexington Equine Surgery and Sports Medicine Equine Veterinary Specialists Georgetown, KY The need for equine field
More informationCommunity Ambulance Service of Minot ALS Standing Orders Legend
Legend Indicates General Information and Guidelines Indicates Procedures Indicates Medication Administration Indicates Referral to Other Protocol Indicates Referral to Online Medical Direction Pediatric
More informationCardiac Arrest VF/Pulseless VT Learning Station Checklist
Cardiac Arrest VF/Pulseless VT Learning Station Checklist VF/VT 00 American Heart Association Adult Cardiac Arrest Shout for Help/Activate Emergency Response Epinephrine every - min Amiodarone Start CPR
More informationAdministrative Manual
I. Description Administrative Manual Policy Name Pediatric Sedation Policy For Non- Anesthesiologists Policy Number ADMIN 0212 Date this Version Effective March 1, 2011 Responsible for Content Pediatric
More informationFeline Anesthesia Richard M. Bednarski, DVM, MSc The Ohio State University College of Veterinary Medicine Current Issues in Feline Anesthesia
Feline Anesthesia Richard M. Bednarski, DVM, MSc The Ohio State University College of Veterinary Medicine Current Issues in Feline Anesthesia Chemical Restraint Protocols Trap, Neuter, Release Anesthetic
More informationProvider Sedation Education
Provider Sedation Education Purpose: To provide sedation education for IU Health physicians and dentists seeking moderate and deep sedation credentials. Credentialing requirements: Moderate sedation credentials:
More informationDRUG and ALCOHOL ABUSE
M12 DRUG and ALCOHOL ABUSE EMS personnel must be aware that alcohol and drug ingestion can mask the symptoms of injury or illness. In addition, many injuries and illnesses can present as suspected alcohol
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Sedation for diagnostic and therapeutic procedures in children and young people 1.1 Short title Sedation in children and young
More informationThe ideal intensive care unit (ICU) sedative CHOICE OF SEDATION FOR CRITICALLY ILL PATIENTS: A RATIONAL APPROACH * PROCEEDINGS. Louis Brusco, Jr, MD
CHOICE OF SEDATION FOR CRITICALLY ILL PATIENTS: A RATIONAL APPROACH * Louis Brusco, Jr, MD ABSTRACT Because no single, ideal sedative exists, the clinician must take care to select the best agent to ensure
More informationPATIENT CARE STANDARD
Sutter Medical Center, Sacramento Nursing POLICY STATEMENT: PATIENT CARE STANDARD It is the policy of hospitals within the Sutter Sacramento Region to provide a uniform, safe, and evidence-based standards
More informationNaloxone Hydrochloride Injection PRODUCT INFORMATION
Naloxone Hydrochloride Injection PRODUCT INFORMATION DESCRIPTION Naloxone hydrochloride is 17-allyl-4,5α-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride; C 19 H 21 NO 4.HCl. It is an off-white powder
More informationGuidelines for the Use of Sedation and General Anesthesia by Dentists
Guidelines for the Use of Sedation and General Anesthesia by Dentists I. Introduction The administration of local anesthesia, sedation and general anesthesia is an integral part of dental practice. The
More informationANESTHETIC AGENTS PRE-ANESTHETICS AND ANALGESICS
ANESTHETIC AGENTS The following provides a very brief overview of the anesthetic agents most commonly used in HSVMA- RAVS small animal protocols. This is NOT a detailed monograph on the listed drugs. Consult
More informationHow To Understand The Effects Of Drugs On The Brain
DRUGS AND THE BRAIN Most of the psychological and behavioural effects of psychoactive drugs is due the interaction they have with the nerve cells in the CNS (which includes the brain and peripheral nervous
More informationUpdate on Buprenorphine: Induction and Ongoing Care
Update on Buprenorphine: Induction and Ongoing Care Elizabeth F. Howell, M.D., DFAPA, FASAM Department of Psychiatry, University of Utah School of Medicine North Carolina Addiction Medicine Conference
More informationGUIDELINE FOR ADMINISTRATION OF FENTANYL FOR PAIN RELIEF IN LABOUR
GUIDELINE FOR ADMINISTRATION OF FENTANYL FOR PAIN RELIEF IN LABOUR INTRODUCTION Intravenous (IV) Fentanyl is a good option for pain management during labour and should be administered in a safe and competent
More informationMEDICATION ABUSE IN OLDER ADULTS
MEDICATION ABUSE IN OLDER ADULTS Clifford Milo Singer, MD Adjunct Professor, University of Maine, Orono ME Chief, Division of Geriatric Mental Health and Neuropsychiatry The Acadia Hospital and Eastern
More informationAbstral Prescriber and Pharmacist Guide
Abstral Prescriber and Pharmacist Guide fentanyl citrate sublingual tablets Introduction The Abstral Prescriber and Pharmacist Guide is designed to support healthcare professionals in the diagnosis of
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: PDP IBT Inj - Vivitrol Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Opiate Antagonist Client: 2007 PDP IBT Inj Approval Date: 2/20/2007
More informationThe Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool
The Pharmacological Management of Cancer Pain in Adults Clinical Audit Tool 2015 This clinical audit tool accompanies the Pharmacological Management of Cancer Pain in Adults NCEC National Clinical Guideline
More informationBlueprint for Prescriber Continuing Education Program
CDER Final 10/25/11 Blueprint for Prescriber Continuing Education Program I. Introduction: Why Prescriber Education is Important Health care professionals who prescribe extended-release (ER) and long-acting
More informationPROFESSIONAL BOARD FOR EMERGENCY CARE
PROFESSIONAL BOARD FOR EMERGENCY CARE IMPORTANT NOTICE TO ALL EMERGENCY CARE PRACTITIONERS INTRODUCTION OF NEW SCOPE OF PRACTICE FOR REGISTERED EMERGENCY CARE PRACTITIONERS NOVEMBER 2009 Herewith the July
More informationTABLE 2 ASA Physical Status Classification
TABLE 2 ASA Physical Status Classification ASA Class I II III IV V Description A normal, healthy patient, without organic, physiologic, or psychiatric disturbances A patient with controlled medical conditions
More informationUpdate on Small Animal Cardiopulmonary Resuscitation (CPR)- is anything new?
Update on Small Animal Cardiopulmonary Resuscitation (CPR)- is anything new? DVM, DACVA Objective: Update on the new Small animal guidelines for CPR and a discussion of the 2012 Reassessment Campaign on
More information